Philippe Conus Selected Research

Glutamate-Cysteine Ligase

1/2016	Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
10/2011	Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.
10/2007	Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Conus Research Topics

Disease

38	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 05/2003
22	Weight Gain 07/2022 - 05/2003
20	Schizophrenia (Dementia Praecox) 03/2022 - 10/2005
7	Mania (Manias) 01/2022 - 10/2006
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 10/2005
5	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2011
4	Hypercholesterolemia 11/2021 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2019
3	Mental Disorders (Mental Disorder) 11/2021 - 07/2008
3	Hypertriglyceridemia 11/2021 - 01/2018
3	Dyslipidemias (Dyslipidemia) 01/2019 - 12/2017
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2022 - 01/2022
2	Neuroinflammatory Diseases 01/2022 - 11/2020
2	Genetic Risk Score 01/2021 - 12/2017
1	Abdominal Obesity 01/2022
1	Hyperglycemia 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Infections 01/2022
1	Personality Disorders (Personality Disorder) 01/2022
1	Disease Progression 01/2022
1	Inflammation (Inflammations) 11/2021
1	Sleep Wake Disorders 01/2021
1	Hyperprolactinemia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Torsades de Pointes (Torsade de Pointes) 01/2019
1	Overweight 01/2018
1	Obesity 10/2015
1	Treatment-Resistant Schizophrenia 01/2011
1	Sudden Death 05/2010

Drug/Important Bio-Agent (IBA)

22	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2005
17	Psychotropic Drugs (Psychoactive Drugs)IBA 07/2022 - 10/2013
15	Antipsychotic Agents (Antipsychotics)IBA 04/2022 - 05/2003
9	Glutathione (Reduced Glutathione)IBA 01/2019 - 10/2007
6	Olanzapine (Zyprexa)FDA Link 04/2022 - 06/2002
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
5	LipidsIBA 01/2022 - 12/2017
5	Cysteine (L-Cysteine)FDA Link 10/2021 - 08/2008
4	CholesterolIBA 01/2022 - 12/2017
4	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 06/2002
4	AntioxidantsIBA 10/2021 - 10/2018
4	Pharmaceutical PreparationsIBA 01/2021 - 07/2011
4	Acetylcysteine (Siran)FDA LinkGeneric 10/2018 - 07/2011
4	EnzymesIBA 01/2016 - 10/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 08/2008
3	ParvalbuminsIBA 01/2022 - 01/2019
3	oxidized low density lipoproteinIBA 11/2021 - 12/2017
3	Quetiapine Fumarate (Seroquel)FDA Link 11/2021 - 10/2006
3	Glutamic Acid (Glutamate)FDA Link 11/2020 - 01/2016
3	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 01/2020 - 08/2013
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 09/2017
3	Glutamate-Cysteine LigaseIBA 01/2016 - 10/2007
2	N 30IBA 01/2022 - 09/2014
2	HDL LipoproteinsIBA 01/2022 - 12/2017
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2017
2	LithiumIBA 01/2022 - 01/2017
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2021
2	Amino Acids FDA Link 11/2021 - 10/2011
2	LDL CholesterolIBA 11/2021 - 09/2017
2	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 01/2018
2	N-Methylaspartate (NMDA)IBA 01/2018 - 08/2008
2	Genetic Markers (Genetic Marker)IBA 12/2017 - 12/2016
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	BenzodiazepinesIBA 04/2022
1	Antidepressive Agents (Antidepressants)IBA 04/2022
1	Paliperidone Palmitate FDA Link 01/2022
1	Chlorpromazine (Thorazine)FDA Link 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	CatecholaminesIBA 11/2021
1	HDL CholesterolIBA 11/2021
1	NucleosidesIBA 11/2021
1	TetrapyrrolesIBA 11/2021
1	pyridineIBA 11/2021
1	didesipramineIBA 11/2021
1	Carboxylic AcidsIBA 11/2021
1	1,7-dimethylxanthine (paraxanthine)IBA 01/2021
1	Theophylline (Theon)FDA LinkGeneric 01/2021
1	methylxanthineIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 11/2020
1	ProlactinIBA 01/2020
1	Amisulpride (Solian)IBA 01/2020
1	ThioredoxinsIBA 12/2018
1	Glutathione PeroxidaseIBA 12/2018
1	PeroxiredoxinsIBA 12/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2017
1	NexusIBA 11/2016
1	PhosphoenolpyruvateIBA 10/2015
1	Fish OilsIBA 01/2015
1	Protons (Proton)IBA 02/2012
1	Sulfhydryl Compounds (Thiols)IBA 10/2011
1	Aripiprazole (Abilify)FDA Link 01/2011
1	Indicators and Reagents (Reagents)IBA 08/2010
1	ElementsIBA 05/2010

Therapy/Procedure

3	Therapeutics 10/2021 - 10/2007
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
2	Aftercare (After-Treatment) 01/2022 - 10/2005
2	Treatment Delay 01/2021 - 02/2015
1	Duration of Therapy 04/2022
1	Patient Readmission 01/2022